DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Sangamo Biosciences, Inc. (NASDAQ: SGMO)

12.25 -0.06 (-0.49%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGMO $12.25 -0.49%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.35
Previous Close $12.31
Daily Range $12.08 - $12.41
52-Week Range $9.39 - $19.25
Market Cap $851.3M
P/E Ratio -35.17
Dividend (Yield) $0.00 (0.0%)
Volume 521,679
Average Daily Volume 843,791
Current FY EPS -$0.57

Sector

Healthcare

Industry

Drug Makers

Sangamo Biosciences, Inc. (SGMO) Description

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes. Website: http://www.sangamo.com/

News & Commentary

Following Hepatitis C, This Could Be the Next Disease Researchers Cure

With an effective cure for hepatitis C now in place after decades of research, we asked three of our top healthcare analysts which disease they believed researchers may cross off the list next. Here's what they had to say.

MKM Partners' 4 Health Care Stocks to Sell Before June

Sangamo Reports Presentation of New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Sto

Sangamo Reports Presentation of New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Storage Disorders at ASGCT

Why Shares of Sangamo Biosciences Fell Today

Shares of Sangamo Biosciences fell hard today after providing a clinical update at the American Society of Gene and Cell Therapy. Is the move meaningful, or just market noise?

Today's Weak On High Volume Stock: Sangamo BioSciences (SGMO)

Sangamo BioSciences Provides Clinical Update On SB-728-T Program

Sangamo BioSciences Announces Joint Steering Committee Decision To Consolidate ZFP Therapeutic® Stra

Sangamo BioSciences Announces Joint Steering Committee Decision To Consolidate ZFP Therapeutic® Strategy For Hemoglobinopathies

3 Tiny Healthcare Stocks You Ought to Be Watching

Celldex Therapeutics, Inc., Exact Sciences Corporation, and Sangamo Biosciences could all have market moving news this year.

Biogen or Bluebird: Which Will Lead in SCD?

Gene Therapy Stocks Take Beating On Bad News For Celladon

See More SGMO News...

SGMO's Top Competitors

SGMO $12.25 (-0.49%)
Current stock: SGMO
AMGN $156.26 (-0.69%)
Current stock: AMGN
GILD $112.27 (-0.51%)
Current stock: GILD
BIIB $396.99 (-0.78%)
Current stock: BIIB